New prognostic score based on galectin-3 has similar performance to model for end-stage liver disease and sodium score in patients with stable decompensated cirrhosis

BACKGROUND: Galectin-3 (gal-3) has been proposed as a marker of established renal impairment, with predictive value in stable decompensated cirrhosis. METHODS: 150 stable decompensated patients were assessed in 2 transplant centers. Patients’ renal function was assessed using (51)Chromium-EDTA (“tru...

Descripción completa

Detalles Bibliográficos
Autores principales: Oikonomou, Theodora, Orfanidou, Afroditi, Goulis, Ioannis, Ntogramatzi, Fani, Athanasiadou, Zoi, Papatheodoridis, George V., Cholongitas, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375656/
https://www.ncbi.nlm.nih.gov/pubmed/34475745
http://dx.doi.org/10.20524/aog.2021.0633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375656/
https://www.ncbi.nlm.nih.gov/pubmed/34475745
http://dx.doi.org/10.20524/aog.2021.0633

Ejemplares similares